Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotarix in HIV Positive Infants
NCT00263666Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Primary completion
- Feb 2008
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rotavirus infection comparing Rotarix Group with Placebo Group (2 arms). Primary endpoint: Number of Subjects Reporting Grade 2 or Grade 3 Fever, Vomiting or Diarrhea. Started Mar 2005; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00263666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263666.